RHUMBLINE ADVISERS

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in LRMR

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$219,258

-$62,824 QoQ

Shares Held

71,888

+14.7% QoQ

Ownership

0.069%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#63

of 162 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 28% Shared 0% None 72%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. LRMR ranks #238 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$219,258	71,888	+14.7%	Shares	Sole	2026-08-12
2026-03-31	$282,082	62,685	-1.4%	Shares	Sole	2026-05-12
2025-12-31	$242,182	63,565	-7.7%	Shares	Sole	2026-02-13
2025-09-30	$222,453	68,871	+2.2%	Shares	Sole	2025-11-06
2025-06-30	$194,664	67,358	+3.6%	Shares	Sole	2025-08-12
2025-03-31	$139,788	65,018	+15.7%	Shares	Sole	2025-05-29
2024-12-31	$217,494	56,200	+0.9%	Shares	Sole	2025-05-29
2024-09-30	$364,710	55,681	+1.4%	Shares	Sole	2024-11-12
2024-06-30	$398,286	54,936	+74.6%	Shares	Sole	2024-08-01
2024-03-31	$238,788	31,461	+11.1%	Shares	Sole	2024-05-09
2023-12-31	$128,865	28,322	-2.1%	Shares	Sole	2024-02-08
2023-09-30	$114,297	28,936	+9.2%	Shares	Sole	2023-11-09
2023-06-30	$82,957	26,504	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.